Ozempic on Medicare in North Carolina: $407 Million in 2023 and the 2027 Negotiated Price

by

Skyler Abilla

Ozempic on Medicare in North Carolina: $407 Million in 2023 and the 2027 Negotiated Price

Ozempic was North Carolina's second most expensive Medicare Part D drug in 2023 at $407 million. Medicare's negotiated price starts in 2027. Here is what that means for you.

The Diabetes Shot Behind $407 Million in North Carolina Medicare Spending

Ranked 43rd in prescriptions. But Ozempic is North Carolina's second most expensive Medicare drug, and it's still climbing.

$407.4M
Total NC Medicare spend on Ozempic (semaglutide), 2023
$1,311
Average cost per prescription, 2023
#43 / #2
Rank by prescriptions / rank by total cost
$274
Medicare's negotiated price for a 30-day supply of semaglutide, starting January 1, 2027

What is Ozempic and why is it such a big deal?

Ozempic (semaglutide) is a once-weekly injectable GLP-1 receptor agonist for Type 2 diabetes. It lowers blood sugar and has demonstrated cardiovascular benefits. Medicare Part D covers it for diabetes, not for weight loss alone. North Carolina's diabetes rate is above the national average, and that disease burden drives significant GLP-1 volume.

Why does it cost $1,311 per prescription?

Novo Nordisk manufactures Ozempic under patent and no generic exists. NC Medicare filled 310,812 Ozempic prescriptions in 2023 at $1,311 each. Metformin, used for the same condition by more than twice as many patients, costs about $10 per prescription, so Ozempic costs 131 times more per fill.

Medicare's negotiated price starts in 2027

Ozempic was picked for the second round of Medicare's price negotiation program under the Inflation Reduction Act. CMS announced a negotiated price of $274 for a 30-day supply of semaglutide, which covers Ozempic, Rybelsus and Wegovy, starting January 1, 2027. The list price CMS compared it with was about $959, so the negotiated price is roughly 71% lower.

That $274 is what Medicare will pay, not a new copay. Your Part D plan still sets your deductible, tier and cost sharing, so your actual savings will not be clear until your plan publishes its 2027 benefits. Read your 2027 Annual Notice of Change to see how your plan will treat Ozempic.

Diabetes drugNegotiated price takes effect
Jardiance, FarxigaJanuary 1, 2026
Ozempic, Rybelsus, WegovyJanuary 1, 2027
TrulicitySelected for negotiation in January 2026; any price would take effect no earlier than January 1, 2028

What this means for Part D enrollees

Plans place Ozempic on different tiers, and prior authorization is common, so compare your specific plans. Part D caps what you pay out of pocket for covered drugs at $2,100 in 2026 and $2,400 in 2027. Once you reach it you pay $0 for covered Part D drugs for the rest of the year, and the Medicare Prescription Payment Plan can spread costs into monthly payments. Check Ozempic specifically in Medicare Plan Finder, because the yearly cost difference between plans can be large for this one drug.

Weight-loss GLP-1s are a separate path

From July 1, 2026 through December 31, 2027, the CMS Medicare GLP-1 Bridge lets eligible Part D enrollees, in a stand-alone drug plan or a Medicare Advantage plan with drug coverage, get Wegovy (injection and tablets), the KwikPen form of Zepbound and Foundayo for a flat $50 monthly copay. It requires prior authorization from your prescriber, it is processed separately from your Part D plan, and the $50 does not count toward your Part D deductible or out-of-pocket cap. It does not change how Ozempic is covered for diabetes.

Talk to a local agent

Skyler Abilla is a licensed Medicare agent serving North Carolina and South Carolina. Bring your medication list and we will check each drug against every plan available at your address. Call (843) 284-6815 or book a free call. For the bigger 2027 picture, read our guide to Medicare Part D in 2027.

NC Medicare filled 310,812 Ozempic prescriptions in 2023 at $1,311 each. Metformin, used for the same condition by more than twice as many NC Medicare patients, costs about $10 per prescription. Ozempic costs 131 times more per fill.
Top 10 North Carolina Drugs by Total Medicare Part D Spending, 2023

Source: CMS Medicare Part D Prescribers by Geography and Drug, 2023 (North Carolina). Negotiated prices: CMS Medicare Drug Price Negotiation Program, as reported by NBC News (November 2025) and NCPA (December 2025). Third-cycle drug list: CMS press release, January 27, 2026. GLP-1 Bridge: CMS program details as summarized by NFP (June 10, 2026). Part D 2027 cap: CMS CY 2027 Rate Announcement (April 2026).

A note on this data: Spending figures come from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescribers by Geography & Drug dataset, 2023. This data covers Medicare Part D only and does not represent commercial insurance, Medicaid, or cash-pay prescriptions. Suppressed values (fewer than 11 beneficiaries) are excluded from totals.

This article is for educational purposes only. Nothing here is medical advice. Talk to your doctor before making any decisions about your medications or treatment. Abilla Advisors does not offer every plan available in your area. For information on all of your options, contact Medicare.gov, 1-800-MEDICARE, or your State Health Insurance Assistance Program (SHIP). This content is not connected with or endorsed by the U.S. Government or the federal Medicare program.

Get a free Medicare plan comparison

Tell us a little about you and a licensed Abilla Advisors agent will call you. No cost, no obligation.

Thank you. Your request was received and a licensed agent will call you soon.
Something went wrong. Please call us at (843) 284-6815.

We do not offer every plan available in your area. To get information on all of your options, contact Medicare.gov, 1-800-MEDICARE, or your local State Health Insurance Assistance Program (SHIP).

Related articles

Get Help – No Cost to You

Get personalized Medicare guidance with no cost and no obligation.